HRSA Tells AbbVie and Amgen Their 340B Contract Pharmacy Restrictions Are Illegal

HHS HRSA building entrance and signage
HRSA sent AbbVie and Amgen letters yesterday telling the companies their restrictions on 340B pricing when providers use contract pharmacies are illegal and must stop or the companies could face stiff civil monetary penalties.

Federal health officials told drug manufacturers AbbVie and Amgen late yesterday their restrictions on 340B pricing when providers use contract pharmacies are illegal and must end or the companies could be fined.

The Health Resources and Services Administration’s last 340B

Read More »

Breaking News

Effort Launched to Create 340C—a Separate Drug Discount Program for Health Centers and Possibly Other Entities

Advocates for Community Health wordmark
National health center group Advocates for Community Health is urging Congress to create a new federal drug discount program named 340C open to health centers, rural hospitals, and federal grantees.

A national community health center association founded last year is launching a campaign to urge Congress to create a separate drug discount program called 340C open to health centers and perhaps rural hospitals and federal grantees.

According to a description

Read More »

With Elections Nearing, Biden Is Ordering HHS to do More to Drive Drug Costs Down

Joe Biden holding microphone
President Biden will sign an executive order today directing HHS to submit a plan in 90 days "to lower drug costs and promote access to innovative drug therapies for Medicare beneficiaries."

President Biden will sign an executive order today directing the U.S. Health and Human Services Department (HHS) “to consider additional actions to further drive down prescription drug costs,” the White House said this morning.

“Under the Executive Order, HHS will

Read More »

340B Report Holding Oct. 28 Webinar on What the Midterm Elections Mean for 340B

Vote Here sign in English, Spanish and Chinese on Election Day
340B Report is holding a webinar Oct. 28 about 340B’s future after the November midterm elections.

Five Washington insiders steeped in knowledge about the 340B program will take part in a 340B Report webinar Oct. 28 about 340B’s future after the November midterm elections.

The event from 1:00 to 2:15 p.m. Eastern is an exclusive free

Read More »

New York Times Investigative Story Aftermath: Leading Local Paper Dives into 340B, Emphasizing its Importance for Community Health Centers

Screengrab of Richmond Times Dispatch, Bon Secours Mercy Richmond Community Hospital article
A Richmond, Va., newspaper ran an Oct. 1 deep dive into 340B's value to health centers in the wake of alleged 340B program misuse by a local health system that has drawn national attention.

In the wake of a recent New York Times investigation into alleged misuse of 340B savings by Catholic health system Bon Secours Mercy in Richmond, Va., a local Richmond newspaper has published a comprehensive look at the purpose and value

Read More »

HRSA Allows Immediate 340B Enrollment in Florida, South Carolina Due to Hurricane

Satellite image Hurricane Ian
A satellite image of Hurricane Ian on Sept. 28 on its approach to Florida as a Category 4 storm.

The U.S. Health Resources and Services Administration (HRSA) has granted Florida and South Carolina 340B program enrollment flexibility, as public health emergencies (PHEs) were declared in both states in the aftermath of Hurricane Ian, which left widespread destruction, flooding, and

Read More »

Groups Representing 340B Hospitals Praise Federal Court Decision Halting Deep Medicare Part B Cuts

U.S. District Court for the District of Columbia building
The federal district court in Washington, D.C. has ordered the government to immediately begin to pay 340B hospitals at full rates for Medicare Part B covered drugs.

In a big victory for 340B hospitals, a federal judge in Washington, D.C. ruled yesterday that the government must immediately begin to pay 340B hospitals the full Medicare Part B drug payment rate for the remainder of calendar year (CY)

Read More »

Fallout from New York Times’s 340B Investigative Piece Continues as Local Media, Policymakers, and Community Weighs In

Screenshot of New York Times Bon Secours Mercy Health hospital article
A New York Times investigative story on the 340B program continues to garner attention both locally and nationally.

Shockwaves from the New York Times’ investigative piece on the alleged misuse of 340B savings by a Catholic health system in Richmond, Virginia continues to spread, as local news outlets and government leaders from all levels respond.  The lengthy article

Read More »

Manchin and Braun Call on HHS To Take Immediate Action Against Drug Manufacturers in Contract Pharmacy Battle

Sen. Joseph Manchin (D-WV) and Sen. Michael Braun (R-IN) headshots
Senators Manchin (D-WV) and Braun (R-Ind.) are urging HHS to take action against drug manufacturers who have placed restrictions in the contract pharmacy setting.

Government health officials need to take immediate action to fully enforce the law against drug makers who are denying 340B drug discounts to providers who use contract pharmacies to dispense 340B-priced drugs, U.S. Senator Joe Manchin (D-W.VA.) and U.S. Senator

Read More »

Generic/OTC Drug Maker Owes Refunds to 340B Providers, HRSA Audit Shows

screenshot of HRSA FY 2022 manufacturer audit results page
HRSA released findings from its audit of drug company VistaPharm.

The U.S. Health Resources Services Administration (HRSA) has ordered South Carolina-based VistaPharm, a manufacturer of generic and over-the-counter (OTC) drugs to repay overcharges to 340B covered entities after a HRSA audit showed the company did not offer its products at the

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report